Urol. praxi, 2015; 16(3): 109-112

Effect of myo-inositol and antioxidants on male fertility

MUDr.Lukáš Bittner, FEBU, FECSM
Urologická klinika 3. LF UK a FNKV, Praha

Infertility is a problem that affects large number of pairs. Treatment of male factor is arduous, especially in the case of idiopathic causes

of infertility. Inositol is a promising agent improving quality of sperm, which effectiveness demonstrates recent studies. Oxidative stress

reduction remains one of the pillars in treatment of idiopathic male infertility.

Keywords: inositol, oxidative stress, antioxidants, male infertility

Published: June 30, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bittner L. Effect of myo-inositol and antioxidants on male fertility. Urol. praxi. 2015;16(3):109-112.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bahat A, Eisenbach M. Human sperm thermotaxis is mediated by phospholipase C and inositol trisphosphate receptor Ca2+ channel. Biol Reprod 2010; 82(3): 606-616. Go to original source... Go to PubMed...
    2. Naaby-Hansen S, Wolkowicz MJ, Klotz K, Bush LA, Westbrook VA, Shibahara H, Shetty J, Coonrod SA, Reddi PP, Shannon J, Kinter M, Sherman NE, Fox J, Flickinger CJ, Herr J,C. Co-localization of the inositol 1,4,5-trisphosphate receptor and calreticulin in the equatorial segment and in membrane bounded vesicles in the cytoplasmic droplet of human spermatozoa. Mol Hum Reprod 2001; 7(10): 923-933. Go to original source... Go to PubMed...
    3. Roldan ER, Shi QX. Sperm phospholipases and acrosomal exocytosis. Front Biosci 2007; 12: 89-104. Go to original source... Go to PubMed...
    4. Colone M, Marelli G, Unfer V, Bozzuto G, Molinari A, Stringaro A. Inositol activity in oligoasthenoteratospermia - an in vitro study. Eur Rev Med Pharmacol Sci 2010; 14(10): 891-896. Go to PubMed...
    5. Yeung CH, Anapolski M, Setiawan I, Lang F, Cooper TG. Effects of putative epididymal osmolytes on sperm volume regulation of fertile and infertile c-ros transgenic Mice. J Androl 2004; 25(2): 216-223. Go to original source... Go to PubMed...
    6. Calogero AE, Gullo G, La Vignera S, Condorelli RA, Vaiarelli A. Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study. Andrology 2015. Go to original source...
    7. Condorelli RA, La Vignera S, Bellanca S, Vicari E, Calogero AE. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology 2012; 79(6): 1290-1295. Go to original source... Go to PubMed...
    8. Rubino P, Palini S, Chigioni S, Carlomagno G, Quagliariello A, De Stefani S, Baglioni A, Bulletti C. Improving fertilization rate in ICSI cycles by adding myoinositol to the semen preparation procedures: a prospective, bicentric, randomized trial on sibling oocytes. J Assist Reprod Genet 2015; 32(3): 387-394. Go to original source... Go to PubMed...
    9. Sanocka D. Reactive oxygen species and sperm cells. Reproductive Biology & Endocrinology 2004: 12-17. Go to original source... Go to PubMed...
    10. Alvarez J, Storey B. Differential incorporation of fatty-acids from phospholipids of huan spermatozoa. Molecular Reproduction and Development 1995; 42(3): 334-346. Go to original source... Go to PubMed...
    11. Yeagle P. Lipids and lipid-intermediate structures in the fusion of biologial membranes. Cell Lipids 1994; 40: 197-214. Go to original source...
    12. Erenpreiss J, Spano M, Erenpreisa J, Bungum M, Giwercman A. Sperm chromatin structure and male fertility: biological and clinical aspects. Asian Journal of Andrology 2006; 8(1): 11-29. Go to original source... Go to PubMed...
    13. Thomas N, Durkie M, Van Zyl B, Sanford R, Potts G, Youings S, Dennis N, Jacobs P. Parental and chromosomal origin of unbalanced de novo structural chromosome abnormalities in man. Human Genetics 2006; 119(4): 444-450. Go to original source... Go to PubMed...
    14. Agarwal A, Saleh R, Bedaiwy M. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertility and Sterility 2003; 79(4): 829-843. Go to original source... Go to PubMed...
    15. Geva E, Lessing J, Bartoov B, LernerGeva L, Zabludovsky N, Amit A. The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertility and Sterility 1996; 66(3): 430-434. Go to original source... Go to PubMed...
    16. Kvíčala J. Zvýšení příjmu mikronutrientu selenu - utopie, fikce, prozřetelnost či nutnost? - II. část. Interní Med. 2003; 7: 354-359.
    17. Safarinejad M, Safarinejad S. Efficacy of Selenium and/or N-Acetyl-Cysteine for Improving Semen Parameters in Infertile Men: A Double-Blind, Placebo Controlled, Randomized Study. Journal of Urology 2009; 181(2): 741-751. Go to original source... Go to PubMed...
    18. Ebisch IM, Pierik FH, DE Jong FH, Thomas CM, Steegers-Theunissen RP. Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl 2006; 29(2): 339-345. Go to original source... Go to PubMed...
    19. Zhou X, Liu F, Zhai S. Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review. Asia Pac J Clin Nutr 2007; 16(Suppl 1): 383-390.
    20. Scibona M, Meschini P, Capparelli S, Pecori C, Rossi P. Menchini Fabris, G. F., [L-arginine and male infertility]. Minerva Urol Nefrol 1994; 46(4): 251-253. Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.